We know that the more we're able to invest, the faster we'll be able to deliver, so we're working hard to raise the funds we need to drive things forward faster.

Driving research forwards

We are proud to have supported a groundbreaking clinical trial led by Dr Alan Whone to test whether an experimental treatment called GDNF can slow, stop or reverse Parkinson’s - something no current treatment can do.